Inhibitory effects of Japanese herbal medicines sho-saiko-to and juzen-taiho-to on nonalcoholic steatohepatitis in mice.
Inhibitory effects of Japanese herbal medicines sho-saiko-to and juzen-taiho-to on nonalcoholic steatohepatitis in mice.
复制标题
DOI:
10.1371/journal.pone.0087279
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Fukusato T
中科院分区:
文献类型:
--
作者:
Takahashi Y;Soejima Y;Kumagai A;Watanabe M;Uozaki H;Fukusato T
Although Japanese herbal medicines (JHMs) are widely used in Japan, only a few studies have investigated their effects on nonalcoholic steatohepatitis (NASH). In the present study, we examined the effect of 4 kinds of JHMs [sho-saiko-to (TJ-9), inchin-ko-to (TJ-135), juzen-taiho-to (TJ-48), and keishi-bukuryo-gan (TJ-25)] on a mouse model of NASH. Db/db mice were divided into 6 groups: control diet (control), methionine- and choline-deficient diet (MCD), and MCD diet supplemented with TJ-9, TJ-135, TJ-48, and TJ-25 (TJ-9, TJ-135, TJ-48, and TJ-25, respectively). All mice were sacrificed after 4 weeks of treatment, and biochemical, pathological, and molecular analyses were performed. Serum alanine aminotransferase levels and liver histology, including necroinflammation and fibrosis, were significantly alleviated in the TJ-9 and TJ-48 groups compared with the MCD group. The expression level of transforming growth factor (TGF)-β1 mRNA in the liver was significantly suppressed by TJ-48. Although the differences were not statistically significant, the expression levels of tumor necrosis factor (TNF)-α and interleukin (IL)-6 were lower, and those of peroxisome proliferators-activated receptor (PPAR)γ were higher in the TJ-9 and/or TJ-48 groups than in the MCD group. Similarly, even though the results were not statistically significant, malondialdehyde levels in liver tissues were lower in the TJ-9 and TJ-48 groups than in the MCD group. We showed that JHMs, especially TJ-9 and TJ-48, inhibited the necroinflammation and fibrosis in the liver of a mouse model of NASH, even though the mechanisms were not fully elucidated. Further studies are needed in the future to investigate the possibility of clinical application of these medicines in the treatment for NASH.
登录
查看更多内容
影响因子:
8.2
作者:
Guo, Hong-xia;Liu, Dai-hua;Peng, Hong-li
通讯作者:
Peng, Hong-li
影响因子:
13.5
作者:
POWELL, EE;COOKSLEY, WGE;POWELL, LW
通讯作者:
POWELL, LW
影响因子:
15.9
作者:
Leclercq, IA;Farrell, GC;Robertson, GR
通讯作者:
Robertson, GR
影响因子:
3.2
作者:
Fujimoto, Makoto;Tsuneyama, Koichi;Shimada, Yutaka
通讯作者:
Shimada, Yutaka
DOI:
10.1097/00042737-200402000-00001
发表时间:
2004-02-01
影响因子:
2.1
作者:
Shek, FW;Benyon, RC
通讯作者:
Benyon, RC